Brief: Magenta Therapeutics Adopts Limited Duration Stockholder Rights Plan
March 31 (Reuters) - Magenta Therapeutics Inc MGTA.O :
* MAGENTA THERAPEUTICS ADOPTS LIMITED DURATION STOCKHOLDER
RIGHTS
PLAN
* MAGENTA THERAPEUTICS INC - RIGHTS PLAN WILL EXPIRE IN ONE
YEAR,
AT CLOSE OF BUSINESS ON MARCH 30, 2024
Source text for Eikon: ID:nGNXZ3j41
Further company coverage: MGTA.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Dianthus Therapeutics
See all newsU.S. RESEARCH ROUNDUP- Adobe, Chewy, Mosaic
Brief: Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies
Dianthus Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Dianthus Therapeutics Q2 net loss widens as R&D costs rise